Results 131 to 140 of about 7,717 (219)
International neuroblastoma risk group consortium: a model of networking for rare cancers. [PDF]
J Natl Cancer InstCohn SL, London WB, Schleiermacher G, Moreno L, Ambros IM, Ambros PF, Bagatell R, Popovic MB, Beiske KH, Berthold F, Birz S, Brisse HJ, Brodeur GM, Brock PR, Burchill S, Eggert A, Federico SM, Fischer M, Furner BT, Hero B, Machin D, Kamijo T, Matthay KK, Nakagawara A, Naranjo A, Pötschger U, Valteau-Couanet D, Watkins MT, Irwin MS, Volchenboum SL, Park JR, Pearson ADJ. +31 moreeuropepmc +1 more sourceSchleiermacher als politischer Charakter
SCHLEIERMACHER ALS POLITISCHER CHARAKTER
Schleiermacher als politischer Charakter / Beyschlag, Willibald (Public Domain) ( - )
Title page ( - )
Text ( - )
Imprint ...Beyschlag, Willibaldcore Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastoma. [PDF]
JHEP RepCendres E, Cornet M, Gautier Z, Pire A, Urvoy N, Morcrette G, Simaga F, Guimier A, Chardot C, Capito C, Schleiermacher G, Masliah-Planchon J, Pierron G, Taddei I, Stoppa-Lyonnet D, Zucman-Rossi J, Romana S, Aerts I, Hirsch TZ. +18 moreeuropepmc +1 more sourceSingle-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. [PDF]
J Immunother Cancer, 2022 Costa A, Thirant C, Kramdi A, Pierre-Eugène C, Louis-Brennetot C, Blanchard O, Surdez D, Gruel N, Lapouble E, Pierron G, Sitbon D, Brisse H, Gauthier A, Fréneaux P, Bohec M, Raynal V, Baulande S, Leclere R, Champenois G, Nicolas A, Meseure D, Bellini A, Marabelle A, Geoerger B, Mechta-Grigoriou F, Schleiermacher G, Menger L, Delattre O, Janoueix-Lerosey I. +28 moreeuropepmc +1 more sourceCo-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma. [PDF]
J Exp Clin Cancer ResMayr L, Mager L, Gabler-Pamer L, Kirchhofer D, Freund J, Schwark K, Lau B, Machreich S, Senfter D, Neumüller M, Lang A, Madlener S, Laemmerer A, Bruckner K, Jaunecker CN, Robl B, Walter R, Schueler J, Peyrl A, Azizi AA, Dorfer C, Roessler K, Spiegl-Kreinecker S, Haberler C, Federico A, Gopisetty A, Schleiermacher G, Pfister SM, Geoerger B, Chesler L, Vassal G, Kool M, Müllauer L, Koschmann C, Berger W, Gojo J, Lötsch D. +36 moreeuropepmc +1 more sourceUse Cases Requiring Privacy-Preserving Record Linkage in Paediatric Oncology. [PDF]
Cancers (Basel)Hayn D, Kreiner K, Sandner E, Baumgartner M, Jammerbund B, Falgenhauer M, Düster V, Devi-Marulkar P, Schleiermacher G, Ladenstein R, Schreier G. +10 moreeuropepmc +1 more sourceCorrection to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as review. [PDF]
Eur J Pediatr, 2020 Van Paemel R, Vlug R, De Preter K, Van Roy N, Speleman F, Willems L, Lammens T, Laureys G, Schleiermacher G, Tytgat GAM, Astrahantseff K, Deubzer H, De Wilde B. +12 moreeuropepmc +1 more sourceDiagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. [PDF]
Neurol Neuroimmunol Neuroinflamm, 2022 Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, Schleiermacher G, Santosh P, Lotze T, Dale RC, Deiva K, Hero B, Klein A, de Alarcon P, Gorman MP, Mitchell WG, Lim M, OMS Study Group. +17 moreeuropepmc +1 more sourceReversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma. [PDF]
Nat Commun, 2023 Thirant C, Peltier A, Durand S, Kramdi A, Louis-Brennetot C, Pierre-Eugène C, Gautier M, Costa A, Grelier A, Zaïdi S, Gruel N, Jimenez I, Lapouble E, Pierron G, Sitbon D, Brisse HJ, Gauthier A, Fréneaux P, Grossetête S, Baudrin LG, Raynal V, Baulande S, Bellini A, Bhalshankar J, Carcaboso AM, Geoerger B, Rohrer H, Surdez D, Boeva V, Schleiermacher G, Delattre O, Janoueix-Lerosey I. +31 moreeuropepmc +1 more source